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VERBOVEN, K., I. WENS, F. VANDENABEELE, A. STEVENS, B. CELIE, B. LAPAUW, P. DENDALE, L. J. C. VAN LOON, P.
CALDERS, and D. HANSEN. Impact of Exercise–Nutritional State Interactions in Patients with Type 2 Diabetes.Med. Sci. Sports Exerc.,
Vol. 52, No. 3, pp. 720–728, 2020. Introduction: This study examines the role of nutritional status during exercise training in patients with type
2 diabetes mellitus by investigating the effect of endurance-type exercise training in the fasted versus the fed state on clinical outcome mea-
sures, glycemic control, and skeletal muscle characteristics in male type 2 diabetes patients.Methods: Twenty-five male patients (glycated
hemoglobin (HbA1c), 57 ± 3 mmol·mol
−1 (7.4% ± 0.3%)) participated in a randomized 12-wk supervised endurance-type exercise interven-
tion, with exercise being performed in an overnight-fasted state (n = 13) or after consuming breakfast (n = 12). Patients were evaluated for
glycemic control, blood lipid profiles, body composition and physical fitness, and skeletal muscle gene expression.Results: Exercise training
was well tolerated without any incident of hypoglycemia. Exercise training significantly decreased whole-body fat mass (−1.6 kg) and in-
creased high-density lipoprotein concentrations (+2 mg·dL−1), physical fitness (+1.7 mL·min−1·kg−1), and fat oxidation during exercise in both
groups (PTIME < 0.05), with no between-group differences (PTIME  GROUP > 0.05). HbA1c concentrations significantly decreased after exer-
cise training (PTIME < 0.001), with a significant greater reduction after consuming breakfast (−0.30% ± 0.06%) compared with fasted state
(−0.08% ± 0.06%; mean difference, 0.21%; PTIME  GROUP = 0.016). No interaction effects were observed for skeletal muscle genes related
to lipid metabolism or oxidative capacity.Conclusions: Endurance-type exercise training in the fasted or fed state do not differ in their efficacy
to reduce fat mass, increase fat oxidation capacity, and increase cardiorespiratory fitness and high-density lipoprotein concentrations or their
risk of hypoglycemia inmale patients with type 2 diabetes. HbA1c seems to be improvedmore with exercise performed in the postprandial compared
with the postabsorptive state.KeyWords: EXERCISE, GLYCEMIC CONTROL, NUTRITIONAL STATUS, TYPE 2 DIABETESMELLITUSxercise or physical activity is considered of key impor- exercise per week, spread over 3–5 d·wk , ideally combinedEtance in the clinical management of patients with type2 diabetes mellitus and has therefore been included in
the guidelines for diabetes prevention and treatment (1). To
pursue reasonable and proper glycemic targets (e.g., glycated
hemoglobin (HbA1c) <6.5% (48 mmol·mol
−1)), current prac-
tice guidelines recommend a structured exercise intervention
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with resistance-type exercise (2). The effectiveness of struc-
tured aerobic exercise training has clearly been recognized
with respect to the improvements in cardiometabolic risk profile,
including improved glycemic control (lower HbA1c concentra-
tions) and increased insulin sensitivity, improved cardiorespira-
tory fitness, reduced (visceral) adiposity, reduced ectopic lipid
stores, lower blood pressure, and improvements in blood lipid
profile (3–6). Furthermore, exercise is also able to improve car-
diac (diastolic) function, resulting from various beneficial remod-
eling processes in the heart of patients with type 2 diabetes (7).
Despite these clinically relevant improvements,much of the incon-
sistency in the responsiveness to exercise training in patients with
type 2 diabetes remains unexplained (8), which advocates for fur-
ther enhancement of the therapeutic benefits of exercise interven-
tion in these patients (9).
For decades, nutrient–exercise interactions have been stud-
ied in the field of sport and exercise science. Of interest, the
importance of timing of acute exercise relative to the timing
of meals has been associated with glycemic control in patients
with type 2 diabetes mellitus (10–12). Changes at different tissue
levels (e.g., skeletal muscle and adipose tissue) can potentially be. Unauthorized reproduction of this article is prohibited.
clinically relevant to the optimization of therapeutic benefits of
physical activity in type 2 diabetes (13), as exercise timing rela-
tive to meal ingestion is rarely considered in designing exercise
training studies, especially in type 2 diabetes patients. Of interest,
the responses to acute exercise in the fed or fasted state in type 2
diabetes revealed that postprandial exercise more consistently led
to reductions in glycemia than prior-meal exercise (in particular
when exercise was commenced 30–90 min postprandial). More
heterogeneous results are reported for blood insulin concentra-
tions, as recently reviewed by Teo et al. (14). It is, however, piv-
otal to examine if these acute effects of a single exercise bout are
translatable to long-term exercise training resulting from consec-
utive exercise bouts, taken into account the possible risks for
(postexercise) hypoglycemia.
Still, as of today, no long-term (i.e., ≥12 wk) randomized,
controlled exercise training interventions with clinical out-
comemeasures and glycemic control as primary focus have re-
ported the effect of the timing of exercise relative to meal
ingestion (15). Of interest, persons with, or at increased risk
of, cardiometabolic disease, such as patients with type 2 diabe-
tes, would be a very relevant population to investigate the
long-term effects of exercise training performed in the
overnight-fasted state. Therefore, the aim of the current study
was to examine the clinical and metabolic effects, and safety
and tolerability of exercise training, with exercise performed
in either the fasted or the fed state (after consuming a break-
fast) in an explorative randomized trial in male patients with
type 2 diabetes. Based on studies that have examined the effect
of a single exercise bout in the fasted versus fed state in type 2
diabetes patients, we hypothesized that exercise training in the
fed state would be more favorable to improve glycemic control.A
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Subjects and randomization. A total of 29 male pa-
tients with type 2 diabetes on blood glucose–lowering medica-
tion were recruited for this explorative randomized trial. Male
patients were included based on clinical diagnosis or
HbA1c ≥ 48 mmol·mol−1 (6.5%), age 40–80 yr, sedentary
life-style (<2-h structured exercise-related activities per week),
and Caucasian ethnicity. Exclusion criteria were as follows:
use of exogenous insulin therapy or clopidogrel treatment;
self-reported history of revascularization, coronary artery, re-
nal, pulmonary disease; and/or orthopedic disease that would
interfere with exercise training. Moreover, patients who were
involved in an exercise training or caloric restriction program
within 1 yr before the study were excluded. Patients were ran-
domly assigned, by envelope, to either 3 months of exercise
training, with exercise being performed in the fasted state (be-
fore standardized breakfast (which followed after training);
FastEx; n = 15) or in the postprandial state (after standardized
breakfast; FedEx; n = 14). To standardize breakfast throughout
the intervention, FedEx patients defined their breakfast for the
training days and maintained this breakfast throughout the en-
tire intervention. Carbohydrate containing beverages were not
allowed during this breakfast, of which the energy content andEXERCISE–NUTRITION INTERACTION IN DIABETES
Copyright © 2020 by the American College of Sports Medicinerelative nutrient composition were comparable between the
FastEx and FedEx groups (Table, Supplemental Digital Con-
tent 1, Relative energy content of breakfast meals, http://
links.lww.com/MSS/B765). Because of lack of motivation
(n = 2) or medical reasons not related to the intervention
(n = 2), 4 patients withdrew from the study, leaving
12 patients in the FedEx group and 13 patients in the FastEx
group (Figure, Supplemental Digital Content 2, Flowchart
and intervention randomization, http://links.lww.com/MSS/
B766). Based on the explorative nature of the study, a post hoc
power was calculated to be 97% (effect size, 0.82; α error
probability, 0.05; total sample size, 24). The study was per-
formed in accordance with the standards set by the latest revi-
sion (2013) of the Declaration of Helsinki and was approved
by the local ethical committees (Jessa Hospital and Hasselt
University, Hasselt, Belgium). Written informed consent was
given by all participating patients after careful explanation
about the nature and risks of the experimental procedures of
the study (registration number NTR4711).
Clinical measurements. Anthropometrics (length and
body weight) were determined, and body composition was
assessed using a dual energy x-ray absorptiometry scan
(Hologic Series Delphi-A Fan Beam X-ray Bone Densitome-
ter). Cardiorespiratory fitness was determined by a maximal
cardiopulmonary exercise test on a cycle ergometer (eBike
Basic; General Electric GmbH, Bitz, Germany), thereby
assessing peak oxygen uptake capacity (V˙O2peak) and work-
load capacity (Wpeak) using a 1-min work stage protocol
(starting workload 40W, incremental workload of 20W). Ox-
ygen uptake (Jaeger Oxycon; Erich Jaeger GmbH, Friedberg,
Germany) and heart rate (using 12-lead electrocardiogram)
measurements were performed continuously. All patients cy-
cled until volitional exhaustion. The test was ended when pa-
tients were no longer able to maintain a cycling frequency of
55 rpm or higher. Peak exercise effort was confirmed when re-
spiratory gas exchange ratio (RER) was ≥1.10, in combination
with dyspnea, and leg and/or general fatigue.
Indirect calorimetry. During a separate submaximal cy-
cling exercise test in the fasted state, energy expenditure
(EE; kJ·min−1) (16), substrate oxidation rates (17), and RER
were calculated from V˙O2 and V˙CO2 determined via indirect
calorimetry (Jaeger Oxycon; Erich Jaeger GmbH) during rest
(in supine position) and at 20%, 40%, and 60% V˙O2peak, re-
spectively. During this test, heart rate was monitored continu-
ously using a 12-lead electrocardiogram.
Blood profiles. After an overnight fast, patients arrived at
8:00 AM to obtain a fasting venous blood sample, which was
centrifuged at 4°C for 10 min at 1000g, and plasma and serum
were stored at −80°C until analysis. Blood samples were mea-
sured once by the clinical laboratory (Jessa Hospital, Hasselt,
Belgium) and were analyzed for glucose, insulin, total choles-
terol, high-density lipoprotein (HDL) cholesterol, low-density
lipoprotein (LDL) cholesterol, plasma triacylglycerols (Roche
Cobas 8000; Roche Diagnostics International Ltd, Rotkreuz,
Switzerland), HbA1c (Menarini HA-8180 HbA1c autoanalyzer;
Menarini Diagnostics, Diegem, Belgium), and C-reactive proteinMedicine & Science in Sports & Exercise® 721
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TABLE 1. Patients’ characteristics.
Variable FedEx FastEx
n 12 13
Age, yr 62 ± 1 60 ± 3
Years since diagnosis 11.6 ± 1.2 8.0 ± 1.9
Smoking 3/12 2/13
HbA1c, mmol·mol
−1 53 ± 2 63 ± 5
HbA1c, % 7.0 ± 0.2 7.9 ± 0.4
Length, cm 175.9 ± 2.0 177.0 ± 1.9
Body weight, kg 94.0 ± 4.5 89.1 ± 3.5
BMI, kg·m−2 30.3 ± 1.3 28.3 ± 0.8
Metformin, n 11 11
Sulfonurea, n 5 1
DPP-4 inhibitor, n 3 6
Insulin secretagogue, n 2 —
GLP-1 agonist, n 2 1
Cardiovascular disease drugs, % 75 46
Lipid-lowering drugs, % 50 62
Vasodilating drugs, % 8 —
Other drugs, % 67 15
Data are mean ± SE.
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Inc., Diamond Diagnostics, Holliston, MA, USA). All coeffi-
cients of variation for these assays were less than 15% (ranging
from 0.95% to 4.22%). Insulin resistance (IR) was assessed via
homeostasis assessment of IR (HOMA-IR), calculated as (fasting
plasma glucose (mmol·L−1)  fasting serum insulin (mU·L−1))/
22.5 (18). Postintervention blood samples were collected at least
72 h after the last exercise session to exclude potential residual ef-
fects of the last acute exercise bout.
Skeletal muscle biopsy. To investigate gene expression
profiles, a skeletal muscle biopsywas taken from the musculus
vastus lateralis under local anesthesia using the Bergström
technique with suction during fasting (>10 h) condition. Die-
tary intake was recorded 3 d before the skeletal muscle biopsy.
A second biopsy was collected after the exercise training inter-
vention (separated by at least 72 h from the last exercise ses-
sion) in both groups, after having copied the 3-d diet diary of
the preintervention biopsy. Expression of genes involved in li-
polysis (ATGL: adipose triglyceride lipase, HSL: hormone
sensitive lipase, PLIN 2 and 5, perilipin 2 and 5), triacylglycerol
synthesis (DGAT 1 and 2: diacylglycerolO-acyltranferase 1 and
2), and fatty acid transport (FABP3: fatty acid binding protein 3,
CD36: fatty acid translocase) were analyzed. Furthermore, mus-
cle gene expression of PPAR-α (peroxisome proliferator–
activated receptor-α: β-oxidation and lipid transport), PGC-1α
(peroxisome proliferator–activated receptor-γ coactivator 1-α:
mitochondrial biogenesis), andCPT1 (carnitine palmitoyl trans-
ferase 1b: mitochondrial transport and oxidation fatty acids)
were determined by reverse transcription polymerase chain re-
action. Expression profiles of genes of interest were normalized
relative to the internal reference gene β-actin. RNA primer se-
quences can be found in the Online Supplemental Methods
(Table, Supplemental Digital Content 3, Details of mRNA
primer sequences, http://links.lww.com/MSS/B767).
Exercise training protocol.All patients participated in a
12-wk individually supervised, endurance-type exercise train-
ing program (three exercise sessions per week) while being
instructed not to change their habitual diet. During each ses-
sion, 25 min of walking (treadmill; Technogym, Zaventem,
Belgium) and 20 min of cycling (Excite Bike; Technogym)
exercise were performed for a total duration of 45 min at an in-
tensity of 65% of baseline V˙O2peak (heart rate based (Polar,
Oy, Finland)). At the end of each training session, calorie con-
sumption data and Borg scores were obtained. Patients in the
FastEx group exercised fasted between 7:30 and 10:00 AM,
followed by breakfast and medication intake within 60 min af-
ter exercise. Patients in the FedEx group exercised in the post-
prandial state between 8:00 and 10:30 AM, after having
consumed a breakfast less than 60 min before exercise. Water
intake was allowed ad libitum during the exercise sessions.
Statistical analysis. Data are expressed as mean ± SEM.
Shapiro–Wilk test indicated normal data distribution for pa-
tients’ characteristics (with the exception of HbA1c), body
composition, physical fitness, indirect calorimetry, and inter-
vention characteristics. Skewed data were ln-transformed be-
fore analysis. Group differences were analyzed using722 Official Journal of the American College of Sports Medicine
Copyright © 2020 by the American College of Sports Medicineindependent-samples t-test or an unpaired Student’s t-test
(Mann–Whitney U test). Intervention effects in both groups
were analyzed with two-way repeated-measures ANOVA
(with preintervention and postintervention as conditions). In
addition to the aforementioned dropouts, one patient from the
FastEx group dropped out during postintervention testing and
was therefore excluded from preintervention–postintervention
analyses. SPSS 22 for Windows was used for all calculations
(IBMCorporation, Armonk, NY, USA). Statistical significance
was set at P < 0.05 (two-tailed).RESULTS
Clinical characteristics. Patients’ characteristics are
presented in Table 1. Before the start of the intervention, pa-
tients in both FastEx and FedEx were comparable in terms
of age, smoking status, diabetes history, HbA1c, body compo-
sition (being overweight or slightly obese), and physical fit-
ness (as represented by relative oxygen uptake (V˙O2peak) and
power output (Wpeak); P > 0.05 for all variables, respectively).
With the exception of two patients on DPP-4 inhibitor treat-
ment (monotherapy), most patients in FastEX were on metfor-
min treatment alone (n = 5) or in combination with either
sulfonylurea (n = 1), DPP-4 inhibitor (n = 4), or GLP-1 agonist
(n = 1) treatment. In the FedEx group, all patients were on
combination therapy, with the exception of one patient. The
dual therapy comprised metformin plus sulfonylurea (n = 4),
insulin secretagogues (n = 2), DPP-4 inhibitor (n = 3), or
GLP-1 agonist (n = 1) treatment, respectively. One patient in
the FedEx group was on tritherapy including metformin, sul-
fonylurea, and GLP-1 agonist treatment. In addition to the di-
abetes treatment, several patients in both groups used other
treatments including blood pressure lowering, antiplatelet,
lipid lowering, or vasodilating therapy (Table 1).
Safety and tolerability. In both FastEx and FedEx, ad-
herence to the exercise sessions was high (91% ± 1% and
94% ± 1% of sessions performed, respectively). Throughout
the intervention period, no hypoglycemic events were reported
during the sessions in either of the groups. Borg scoreshttp://www.acsm-msse.org
. Unauthorized reproduction of this article is prohibited.
indicated good tolerability and remain stable during the in-
tervention period (PTIME > 0.1 and PTIME  GROUP > 0.1),
with a mean score of 12.0 ± 0.4 in the FedEx and
10.6 ± 0.3 in the FastEx during the last 3 wk of the interven-
tion period (PGROUP = 0.098).
Body composition and physical fitness. The inter-
vention progressively led to an increased EE during the
sessions (PTIME < 0.001), resulting in 1669 ± 121 and
1715 ± 133 kJ per session on average in FastEx and FedEx,
respectively (PGROUP = 0.902, PGROUP  TIME = 0.434). This
increased EEwas associated with an improved body composi-
tion, as shown by significant reductions in body weight
(PTIME = 0.020), body fat percentage (PTIME = 0.001), and
body fat mass (PTIME < 0.001) while preserving fat-free mass
(PTIME = 0.808) in both FastEx and FedEx (PGROUP and
PTIME  GROUP > 0.1 for all variables). Fat mass significantly
decreased only at the gynoid level (PTIME = 0.009), to the same
extent in both groups (PTIME  GROUP > 0.1). Physical fitness
(V˙O2peak/FFM and Wpeak/FFM) improved significantly after the
12-wk intervention (PTIME < 0.05) in both FastEx and FedEx
(PGROUP and PTIME  GROUP > 0.1; Table 2).
Metabolic blood profile. The exercise intervention was
associated with decreased blood HbA1c concentrations in
both groups (PTIME < 0.001) whereby the reduction was the
highest in the FedEx group compared with the FastEx group
(PTIME  GROUP = 0.016). Fasting plasma glucose, serum
insulin concentrations, and corresponding HOMA-IR values
did not change after the intervention (PTIME and PTIME 
GROUP > 0.1, respectively; Fig. 1 and Table 2). Regarding lipid
metabolism, the intervention was associated with increased
plasma HDL cholesterol concentrations (PTIME = 0.019), simi-
larly (PTIME  GROUP = 0.524) in both FedEx and FastEx. Total
cholesterol, LDL cholesterol, and triglyceride concentrationsTABLE 2. Clinical and metabolic effects of a 12-wk exercise training intervention in the fed or faste
FedEX (n = 12)
Pre Post Pre
Body composition
Body weight, kg 94.0 ± 4.5 93.5 ± 4.5 90.7 ±
BMI, kg·m−2 30.3 ± 1.3 30.1 ± 1.3 28.8 ±
Body fat, % 33.3 ± 1.5 31.9 ± 1.8 32.0 ±
Body fat mass, kg 30.2 ± 2.6 28.5 ± 2.6 27.5 ±
Android fat, kg 3.0 ± 0.3 3.0 ± 0.3 3.0 ±
Gynoid fat, kg 3.8 ± 0.2 3.7 ± 0.2 3.5 ±
FFM, kg 58.7 ± 2.0 58.7 ± 2.0 58.0 ±
Physical fitness
V˙O2peak, mL·min
−1 2296 ± 199 2314 ± 188 2229 ±
V˙O2peak, mL·min
−1·kg−1 (FFM) 39.5 ± 3.7 39.7 ± 3.2 38.8 ±
Wmax, W·kg−1 (FFM) 2.9 ± 0.2 3.1 ± 0.2 2.8 ±
RER peak 1.15 ± 0.01 1.20 ± 0.02 1.19 ±
HR peak, bpm 144 ± 6 140 ± 6 153 ±
Blood profile
HbA1c, % 6.6 [6.3–7.5] 6.3 [6.0–6.9] 7.4 [6.8
Total cholesterol, mg·dL−1 137 [115–170] 138 [118–188] 147 [124
LDL cholesterol, mg·dL−1 65 [49–98] 68 [55–120] 84 [64–
HDL cholesterol, mg·dL−1 45 [38–52] 46 [41–57] 39 [27–
Triglycerides, mg·dL−1 105 [72–140] 94 [83–111] 141 [97–
CRP, mg·dL−1 1.6 [0.6–2.5] 0.9 [0.5–2.0] 1.2 [0.5
Glucose, mg·dL−1 138 [104–193] 131 [96–162] 171 [121
Insulin, mIU·L−1 17.3 [7.3–27.4] 18.7 [9.2–24.5] 13.2 [7.3
HOMA-IR 7.7 [1.8–9.3] 7.9 [2.8–8.6] 4.5 [2.8
Data are mean ± SE. For blood profiles, data are median [interquartile range]. Bolded values are sig
FFM, fat-free mass; Wmax, maximal power output.
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Copyright © 2020 by the American College of Sports Medicineremained unchanged in both groups after the intervention
(PTIME and PTIME  GROUP > 0.05, respectively). The exercise
intervention was not associated with changes in plasma CRP
concentrations (PTIME and PTIME  GROUP > 0.1; Table 2). In-
dividual responses for all blood parameters in both groups are
shown in Figure 1.
Substrate oxidation and EE. The exercise intervention
was associated with a significantly increased resting EE in both
FedEx and FastEx (PTIME = 0.024, PTIME  GROUP = 0.623;
Figure, Supplemental Digital Content 4, Energy expenditure
at rest and during submaximal exercise bouts before (white
bars) and after intervention (black bars) in the fed (A) or
fasted (B) state, http://links.lww.com/MSS/B768) without
any changes in substrate oxidation rates (Table 3). During
the submaximal exercise test in the fasted state, EE did not
change after the intervention (PTIME > 0.1 and PTIME 
GROUP > 0.1, respectively; Figure, Supplemental Digital
Content 4, Energy expenditure at rest and during submaxi-
mal exercise bouts before (white bars) and after intervention
(black bars) in the fed (A) or fasted (B) state, http://links.
lww.com/MSS/B768). However, exercise training either
performed in the fed or fasted state was associated with a
switch in fasting substrate oxidation during the different
submaximal cycling intensities, whereby carbohydrate oxidation
rates decreased (PTIME < 0.05 for the bouts of lowest (20%
V˙O2peak) and highest (60% V˙O2peak) intensity), and fat oxidation
rates increased similarly in both groups (PTIME < 0.05 for all
three intensities; Table 3).
Skeletal muscle mRNA expression. Gene expression
profiles of fasting skeletal muscle samples are shown in
Figure 2. After the intervention, a significant time effect
was found only for PGC-1α and IRS-1 mRNA expression
(PTIME = 0.017 and 0.035, respectively), without any interactiond state.
FastEx (n = 12)
P Time P Group P Time  GroupPost
3.3 90.0 ± 3.4 0.020 0.554 0.641
0.7 28.5 ± 0.7 0.023 0.309 0.575
1.2 30.8 ± 1.3 0.001 0.565 0.829
1.7 26.0 ± 1.8 <0.001 0.425 0.785
0.2 3.0 ± 0.2 0.261 0.989 0.547
0.2 3.4 ± 0.2 0.009 0.515 0.621
2.0 57.8 ± 2.0 0.808 0.771 0.711
153 2415 ± 185 0.039 0.935 0.112
2.8 41.8 ± 2.9 0.047 0.876 0.101
0.1 3.1 ± 0.2 0.008 0.909 0.468
0.02 1.22 ± 0.02 0.026 0.421 0.611
5 152 ± 6 0.136 0.168 0.963
–8.2] 7.7 [6.7–8.3] <0.001 0.079 0.016
–163] 145 [121–164] 0.874 0.597 0.067
104] 82 [59–94] 0.914 0.488 0.08
40] 40 [27–45] 0.019 0.067 0.524
170] 122 [76–143] 0.307 0.029 0.417
–2.1] 1.5 [0.5–8.1] 0.879 0.966 0.160
–186] 165 [132–171] 0.875 0.241 0.311
–18.7] 11.1 [7.9–14.4] 0.294 0.044 0.748
–8.5] 4.0 [3.1–6.5] 0.181 0.163 0.667
nificant.
Medicine & Science in Sports & Exercise® 723
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FIGURE 1—Individual responses of HbA1c, fasting plasma glucose, serum insulin, and CRP concentrations (upper panel) and total cholesterol, HDL cho-
lesterol, LDL cholesterol, and triglycerides concentrations (lower panel) before and after exercise training in the fed or fasted state. **P < 0.01 for total group.
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ESeffect. Of interest, CPT1-β, PLIN5, PLIN2, and GLUT4 mRNA
expression tended to be reduced over time (PTIME < 0.10). Gene
expression of other genes displayed in Figure 2 was not signifi-
cantly different.DISCUSSION
In the present study, we observed that the benefits of pro-
longed endurance-type exercise training on body composition,TABLE 3. Substrate oxidation rates during submaximal exercise before and after exercise training.
FedEx (n = 12)
Pre Post Pre
Carbohydrate oxidation, g·min−1
At rest 0.21 ± 0.05 0.23 ± 0.02 0.21 ± 0
At 20% V˙O2peak 0.49 ± 0.07 0.38 ± 0.05 0.54 ± 0
At 40% V˙O2peak 1.10 ± 0.09 0.86 ± 0.11 1.18 ± 0
At 60% V˙O2peak 2.16 ± 0.29 1.73 ± 0.22 2.42 ± 0
Fat oxidation, g·min−1
At rest 0.03 ± 0.01 0.03 ± 0.01 0.03 ± 0
At 20% V˙O2peak 0.16 ± 0.03 0.23 ± 0.02 0.15 ± 0
At 40% V˙O2peak 0.05 ± 0.02 0.15 ± 0.03** 0.04 ± 0
At 60% V˙O2peak −0.16 ± 0.06 0.02 ± 0.04** −0.22 ± 0
Data are mean ± SE. Substrate oxidation rates during submaximal cycling bouts at three different i
values are significant.
*Significantly different from preintervention values (P < 0.01).
**Significantly different from preintervention values (P < 0.051).
724 Official Journal of the American College of Sports Medicine
Copyright © 2020 by the American College of Sports Medicineexercise performance, and cardiometabolic risk factors did not
differ when exercise was performed in either a postabsorptive
or a postprandial state in male patients with type 2 diabetes.
However, HbA1c improved to a greater extent when exercise
was performed in the fed as opposed to the fasted state.
The role of feeding status on different aspects of glycemic
control is currently under intense but relevant debate, espe-
cially in terms of optimizing prevention and treatment strate-
gies for metabolic diseases (15). Acute exercise of moderateFastEx (n = 11)
P Time P Group P Time  GroupPost
.03 0.29 ± 0.04* 0.123 0.599 0.294
.07 0.44 ± 0.09 0.042 0.530 0.888
.15 1.04 ± 0.12 0.083 0.375 0.638
.30 2.02 ± 0.24 0.026 0.429 0.909
.01 0.01 ± 0.01** 0.557 0.385 0.163
.02 0.20 ± 0.03** 0.015 0.456 0.684
.04 0.09 ± 0.04 0.024 0.407 0.371
.08 −0.08 ± 0.07 0.005 0.327 0.708
ntensities. No differences between groups were observed (P Time  Group > 0.1). Bolded
http://www.acsm-msse.org
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FIGURE 2—Relative skeletal muscle gene expression profiles before (black and gray bars for the FastEx and FedEx group, respectively) and after interven-
tion (white and squared bars for the FastEx and FedEx group, respectively) in the fed or fasted state. Data represent means ± SEM, expressed in arbitrary
units; n = 9 in FastEx and n = 10 in FedEx. Data were normalized to β-actin and baseline (i.e., preintervention values (black and gray bars, respectively)).
*P < 0.05 between preintervention and postintervention by paired t-tests (when time effect was observed or showed a tendency). No intervention effects were
observed between groups.
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ESintensity in the fed state has been described to more consis-
tently ameliorate glucose concentrations compared with
fasted-state exercise in patients with type 2 diabetes (10,19,20).
Of interest, the most optimal timing to perform exercise was sug-
gested to be midpostprandial (i.e., 30–90 min postmeal) (10,14).
In the present study, the FedEx group performed their exercise
sessions within this time frame, during which hepatic gluconeo-
genesis and free fatty acids release are suppressed, thereby
draining meal-derived glucose from the blood using moderate-
intense aerobic exercise. In agreement, the FedEx group showed
greater reductions in blood HbA1c content when compared with
the FastEx group. However, we did not observe a greater decline
in fasting blood glucose concentrations in the FedEx compared
with the FastEx group. These results also seem to corroborate re-
cent meta-analyses reporting exercise-induced improvements in
long-term glycemic control (HbA1c) (21,22) without changes
in fasting blood glucose concentrations (23) in individuals with
type 2 diabetes. Evaluating glycemic control exclusively based
on HbA1c would be reductive, as it does not imply glycemic
variability or the frequency of hypoglycemic events in daily life,
two important aspects related to glycemic control, which could
be different among patients with comparable HbA1c or fasting
glucose concentrations (1). Of interest, nutritional behavior
(especially carbohydrate consumption) may also be persua-
sive in affecting HbA1c concentrations (24) and thus may
mimic true improvements in glycemic control. However, as
the current study lacks standardized tests (e.g., an oral glucose
tolerance test or continuous glucose monitoring) or wide-
ranging diet logs, we could not interpret these facets. Never-
theless, the importance of lowering HbA1c is pivotal because
it is linked to mortality (25) and diabetes complications (26),EXERCISE–NUTRITION INTERACTION IN DIABETES
Copyright © 2020 by the American College of Sports Medicineapart from its link with postprandial hyperglycemia, which
might be even more important in the management of diabetes
patients with HbA1c < 7.5%–8% (27). Accordingly, preexercise
nutritional state should be considered in future exercise in-
tervention studies, as exercise performed in the postprandial
state may result in an overall more effective improvement in
glycemic control. However, individual standardization of
preexercise nutritional status will not reduce variability in
dietary habits in the general patient population, and thus, one
should search for other approaches in this regard (e.g., practical
guidelines onwhen to perform physical activity or exercise with
respect to food intake or choice). Interestingly, improvements in
glycemic control after prolonged endurance-type training are
also related to the efficacy of an exercise training program to
improve body composition (i.e., lower body fat mass and aug-
ment fat-free mass).
One of the myths in weight loss therapies is the belief that
exercise performed in the overnight-fasted state will result in
greater fat mass loss when implemented in an exercise training
program. Both groups showed a significant reduction in
whole-body fat mass (mean fat mass loss of 1.54 ± 0.26 kg),
with most fat lost in the gynoid region and no measurable loss
of fat-free mass. However, no differences were observed in the
amount of fat mass loss between the FedEx and FastEx
groups. These findings in type 2 diabetes patients seem to be
in line with a recent systematic review postulating no addi-
tional benefit of exercise training in the fasted state with re-
spect to body composition changes or fat mass loss, in
healthy young individuals and overweight/obese sedentary
women after short-term (4–6 wk) interventions (28). However,
focusing solely on fat mass loss does not take physiologicalMedicine & Science in Sports & Exercise® 725
. Unauthorized reproduction of this article is prohibited.
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ESadaptations into account which take place with altered body
weight and, particularly, altered body composition (29). In this
regard, energy balance is a main determinant of weight loss
because it considers both food intake and EE. Here, EE (Fig-
ure, Supplemental Digital Content 4, Energy expenditure at
rest and during submaximal exercise bouts before (white bars)
and after intervention (black bars) in the fed (A) or fasted (B)
state, http://links.lww.com/MSS/B768) increased in both
groups, presumably due to the sustained or slightly increased
lean tissue mass in both groups. In addition, substrate oxida-
tion rates shifted equally to more fat oxidation capacity (in
the fasted state) after the interventions in both groups. To-
gether with the sustained whole-body EE, this may result in
a similar negative energy balance between groups, considering
no or little compensation of energy intake to every acute exer-
cise bout (15). With respect to weight maintenance or weight
loss, however, investigating 24-h energy intake following
fasted and fed state exercise would have been more clinically rele-
vant. Unfortunately, one of the main limitations in the current
studywas the lack of postexercise nutritional behavior assessment.
The lack of greater fat mass loss after exercise performed in
the fasted versus fed state in the present study may also be, at
least partly, explained by the insulin resistant state and impair-
ments in adipose tissue lipid mobilization typically observed
in individuals with obesity and type 2 diabetes (30). The rela-
tive high blood insulin concentrations chronically present in
insulin-resistant individuals with type 2 diabetes are responsi-
ble for the antilipolytic state of the adipose tissue (31),
restricting fat mass loss. Besides body fat mass, the effect on
blood lipid profile was investigated in the current study. In line
with previous work (32), we observed a significant improve-
ment in HDL cholesterol after the endurance-type training in-
tervention, which did not alter other lipid levels. Although
there were no specific expectations of divergent benefits of ex-
ercise performed in the fasted or fed state on lipid profiles, we
did look for specific differences between groups. The applied
exercise intervention was not associated with changes in other
lipid profile variables or CRP concentrations. Although the
observed body fat mass loss did not translate into improve-
ments in blood lipid profiles, regular aerobic exercise (as pre-
scribed by the current guidelines (1)) is beneficial for ectopic
(e.g., visceral and liver) fat mass reduction, irrespective of
clinically relevant fat mass loss (5).
In addition to a disturbed adipose tissue lipid mobilization,
the observed similarity in fat mass loss between groups
may partly be explained by a parallel shift in substrate oxi-
dation and an increase in fat oxidation capacity during low-
to-moderate intense exercise (20%–60% V˙O2peak), as stated
earlier. Individuals with type 2 diabetes are known to demon-
strate lower lipid oxidation rates per fat-free mass (33).
Cross-sectional studies indicated a decreased (34) or similar
(35,36) total lipid oxidation during moderate-intense exercise
in type 2 diabetes patients compared with body mass index
(BMI)–matched individuals, yet relying less on plasma-
derived fatty acids and more on intramyocellular and/or very-
low-density lipoprotein lipids (34). The presence of different726 Official Journal of the American College of Sports Medicine
Copyright © 2020 by the American College of Sports Medicinedegrees of insulin sensitivity (37) and the variability in metfor-
min dose (38) may confound these findings and complicate the
relationship between lipid oxidative capacity and type 2 diabe-
tes presence in metabolic diseases. Based on the collection of
muscle biopsies, only muscle mRNA expression for PGC-1α
and PLIN-2 reduced significantly as a result of exercise inter-
vention in the FedEx group. These data may suggest that post-
transcriptional pathways may have become more efficient
because significant chronic adaptations in clinical outcome
measures were noticed within the same time frame (e.g., body
composition, fat oxidation, and exercise tolerance).
One of the fears when performing exercise in the fasted
state in patients with type 2 diabetes is the risk of hypoglyce-
mic events, especially in those treated with long-acting sulfo-
nylureas (39). In general and resulting from compensatory
endocrine changes (involving insulin, glucagon, and catechol-
amines), stable or slightly elevated blood glucose concentra-
tions are often reported during acute (≤60-min duration)
endurance-type exercise performed in the fasted state in
healthy individuals (13). In the present study, we did not no-
tice any hypoglycemic symptoms (based on personal commu-
nications with the participants or subjective observations by
the supervisors) before or after the exercise sessions in either
FastEx or FedEx for a total of 804 exercise sessions, which
is in line with previous studies (39,40). Endurance-type exercise
in the postprandial state, as applied in this study (midpostprandial),
is suggested to minimize postexercise hypoglycemic events in pa-
tients with type 2 diabetes (10). Based on our findings, both exer-
cise training approaches are well tolerated (based on Borg scale
results) and safe to perform, although caution should be taken in
interventions of different intensities, durations, or modalities (22).
The relative small sample size and inclusion of patients with
type 2 diabetes, who were treated with blood glucose–lowering
medication only, restrict the generalization of our findings to the
entire type 2 diabetes patient population. Superior benefits in
terms of glycemic control may be achieved when a combined
training regimen, including endurance and resistance-type exer-
cise, would have been applied (1). Furthermore, datawith respect
to physical activity levels (outside the intervention) were not
reported in the current study and detailed data regarding post-
exercise eating behavior lack, which makes it difficult to firmly
draw conclusions about long-term effects of breakfast timing
relative to exercise in this population.With respect to nutritional
status and exercise in metabolic diseases, it would be valuable
to gain more insight into the tissue-specific mechanisms taking
place in, for example, adipose tissue or skeletalmuscle, for which
functional protein expression data are fundamental.
In conclusion, prolonged endurance-type exercise training
in the fasted or fed state is both safe and effective. The applied
exercise intervention was associated with reduced fat mass,
improved exercise performance, and increased HDL concen-
trations in male patients with type 2 diabetes, irrespective of
preexercise nutritional status. HbA1c seems to be improvedmore
with exercise performed in the postprandial state, although daily
glycemic variability and hypoglycemic events should be consid-
ered in future research to validate clinical meaningfulness in thishttp://www.acsm-msse.org
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population. However, healthcare professionals should consider
the timing of exercise and food intake in defining individual
goals for patients with chronic metabolic disease.
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